Potential mediators of improvement in painful chemotherapy-induced peripheral neuropathy via a web-based cognitive behavioural intervention

Potential mediators of improvement in painful chemotherapy-induced peripheral neuropathy via a web-based cognitive behavioural intervention

Purpose: Preliminary evidence suggests that a self-guided cognitive and behaviourally-based pain management intervention (PROSPECT) is effective for chronic painful chemotherapy-induced peripheral neuropathy (CIPN), but its mechanism of action is unknown. The purpose of this secondary analysis was t...

Full description

Bibliographic Details
Main Authors:	Robert Knoerl, Deborah L. Barton, Janean E. Holden, John C. Krauss, Beth LaVasseur, Ellen M.L. Smith
Format:	Article
Language:	English
Published:	Pappin Communications 2018-07-01
Series:	Canadian Oncology Nursing Journal
Subjects:	chronic pain chemotherapy-induced peripheral neuropathy cognitive behaviour therapy peripheral nervous system disease/chemically induced
Online Access:	http://canadianoncologynursingjournal.com/index.php/conj/article/view/910

Similar Items

Characterization of Internal Validity Threats to Phase III Clinical Trials for Chemotherapy-Induced Peripheral Neuropathy Management: A Systematic Review
by: Deborah Lee, et al.
Published: (2019-01-01)

Treatment strategies for chemotherapy-induced peripheral neuropathy: potential role of exercise
by: Karen Y. Wonders, et al.
Published: (2011-12-01)

Falls and Functional Impairments in Breast Cancer Patients with Chemotherapy-Induced Peripheral Neuropathy
by: Hiroko Komatsu, et al.
Published: (2019-01-01)

Associations between self-reported diet during treatment and chemotherapy-induced peripheral neuropathy in a cooperative group trial (S0221)
by: Jennifer M. Mongiovi, et al.
Published: (2018-11-01)

Therapeutic Effects of Phytochemicals and Medicinal Herbs on Chemotherapy-Induced Peripheral Neuropathy
by: Gihyun Lee, et al.
Published: (2016-09-01)

Managing treatment-related peripheral neuropathy in patients with multiple myeloma
by: Grammatico S, et al.
Published: (2016-06-01)

Physiotherapy management of chemotherapy-induced peripheral neuropathy in Pretoria, South Africa
by: Esther A. Niemand, et al.
Published: (2020-10-01)

The Role of Nucleotide Excision Repair in Cisplatin-Induced Peripheral Neuropathy: Mechanism, Prevention, and Treatment
by: Scarlett Acklin, et al.
Published: (2021-02-01)

Characteristics and Quality of Life in Gynecologic Cancer Patients with Chemotherapy-induced Peripheral Neuropathy
by: Ju Hyeon Jeong, et al.
Published: (2013-12-01)

Chemotherapy-Induced Peripheral Neuropathy and Physiotherapy
by: Gro S. Haugen, et al.
Published: (2013-04-01)

Emerging Pharmacological and Non-Pharmacological Therapeutics for Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy
by: Yang Li, et al.
Published: (2021-02-01)

Whole-body vibration as a modality for the rehabilitation of peripheral neuropathies: implications for cancer survivors suffering from chemotherapy-induced peripheral neuropathy
by: Anna L.J. Verhulst, et al.
Published: (2015-02-01)

Risk factors for chemotherapy‐induced peripheral neuropathy in patients receiving taxane‐ and platinum‐based chemotherapy
by: Alex Molassiotis, et al.
Published: (2019-06-01)

Exploring the efficacy of an electronic symptom assessment and self-care intervention to preserve physical function in individuals receiving neurotoxic chemotherapy
by: Robert Knoerl, et al.
Published: (2018-12-01)

Ten weeks of home-based exercise attenuates symptoms of chemotherapy-induced peripheral neuropathy in breast cancer patients
by: Karen Y. Wonders, et al.
Published: (2013-09-01)

Modulation by Ozone Therapy of Oxidative Stress in Chemotherapy-Induced Peripheral Neuropathy: The Background for a Randomized Clinical Trial
by: Bernardino Clavo, et al.
Published: (2021-03-01)

Spinal Cord Stimulation as a Treatment Option for Refractory Chemotherapy-Induced Peripheral Neuropathy: Case Report
by: Arthur Lopes, et al.
Published: (2020-06-01)

Impact of Chemotherapy-Induced Peripheral Neuropathy on Quality of Life in Patients with Advanced Lung Cancer Receiving Platinum-Based Chemotherapy
by: Hsing-Wei Hung, et al.
Published: (2021-05-01)

Assessing gait, balance, and muscle strength among breast cancer survivors with chemotherapy-induced peripheral neuropathy (CIPN): study protocol for a randomized controlled clinical trial
by: Adams, A., et al.
Published: (2022)

The efficacy and safety of electro-acupuncture for alleviating chemotherapy-induced peripheral neuropathy in patients with coloreactal cancer: study protocol for a single-blinded, randomized sham-controlled trial
by: Kaiyin Chan, et al.
Published: (2020-01-01)

Managing Chronic Kidney Disease and Chemotherapy-Induced Peripheral Neuropathy with Acupuncture and Herbal Medicine: A Case Study
by: Sunny-Kim Barden
Published: (2017-04-01)

Taxane-Induced Peripheral Neurotoxicity
by: Roser Velasco, et al.
Published: (2015-04-01)

Integrated Medicine for Chemotherapy-Induced Peripheral Neuropathy
by: Chih-Hung Tsai, et al.
Published: (2021-08-01)

Drug Repositioning for the Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy: A Mechanism- and Screening-Based Strategy
by: Shota Yamamoto, et al.
Published: (2021-01-01)

Small extracellular vesicles ameliorate peripheral neuropathy and enhance chemotherapy of oxaliplatin on ovarian cancer
by: Yi Zhang, et al.
Published: (2021-03-01)

Redefining chemotherapy-induced peripheral neuropathy through symptom cluster analysis and patient-reported outcome data over time
by: Mian Wang, et al.
Published: (2019-11-01)

Genetic Predictors of Chemotherapy-Induced Peripheral Neuropathy from Paclitaxel, Carboplatin and Oxaliplatin: NCCTG/Alliance N08C1, N08CA and N08CB Study
by: Araba A. Adjei, et al.
Published: (2021-03-01)

Neuroinflammatory Process Involved in Different Preclinical Models of Chemotherapy-Induced Peripheral Neuropathy
by: Giulia Fumagalli, et al.
Published: (2021-02-01)

A HOME-BASED EXERCISE PROGRAM TO IMPROVE NEUROMUSCULAR AND SPATIO-TEMPORAL GAIT PARAMETERS IN A MULTIPLE MYELOMA CANCER SURVIVOR WITH CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY: A CASE REPORT
by: Timothy F. Marshall, et al.
Published: (2019-08-01)

Physiopathological Role of Neuroactive Steroids in the Peripheral Nervous System
by: Eva Falvo, et al.
Published: (2020-11-01)

A new approach to characterize postural deficits in chemotherapy-induced peripheral neuropathy and to analyze postural adaptions after an exercise intervention
by: Sarah Kneis, et al.
Published: (2020-01-01)

Investigating the Role of Nicotinic Acetylcholine Receptor Agonists in Lung Cancer Progression and Chemosensitivity in the Context of Treating Chemotherapy-Induced Peripheral Neuropathy
by: Kyte, Sarah L
Published: (2018)

New Insights into Potential Prevention and Management Options for Chemotherapy-Induced Peripheral Neuropathy
by: Janet Schloss, et al.
Published: (2016-01-01)

Predictive Biomarkers of Oxaliplatin-Induced Peripheral Neurotoxicity
by: Roser Velasco, et al.
Published: (2021-07-01)

Subcutaneous ω-Conotoxins Alleviate Mechanical Pain in Rodent Models of Acute Peripheral Neuropathy
by: Md. Mahadhi Hasan, et al.
Published: (2021-02-01)

Quantitative sensory profiles of upper extremity chemotherapy induced peripheral neuropathy: Are there differences in sensory profiles for neuropathic versus nociceptive pain?
by: Elizabeth Andersen Hammond, et al.
Published: (2019-01-01)

Chemotherapy-Induced Peripheral Neuropathy and Changes in Cytoskeleton
by: Alessio Malacrida, et al.
Published: (2019-05-01)

Sigma-1 receptor: a new player in neuroprotection against chemotherapy-induced peripheral neuropathy
by: Jordi Bruna, et al.
Published: (2018-01-01)

Vagus Nerve Stimulation Transiently Mitigates Chemotherapy-Induced Peripheral Neuropathy in Rats
by: Zhang R, et al.
Published: (2020-12-01)

Presence and Distress of Chemotherapy-Induced Peripheral Neuropathy Symptoms in Upper Extremities of Younger and Older Breast Cancer Survivors
by: Susan Storey, et al.
Published: (2020-10-01)